Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCap-xx Regulatory News (CPX)

Share Price Information for Cap-xx (CPX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.0775
Bid: 0.075
Ask: 0.08
Change: -0.0055 (-6.63%)
Spread: 0.005 (6.667%)
Open: 0.083
High: 0.083
Low: 0.0775
Prev. Close: 0.083
CPX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Offer to Qualifying Participants

24 Dec 2019 07:00

RNS Number : 9073X
CAP-XX Limited
24 December 2019
 

24 December 2019

 

CAP-XX Limited

("CAP-XX" or the "Company")

Result of Offer to Qualifying Participants

 

CAP-XX Limited, a world leader in the design and manufacture of thin, prismatic supercapacitors and energy management systems, announced on 29 November 2019 a fundraising that included an Offer to Qualifying Participants of up to 25,000,000 Offer Shares at an Issue Price of 3p per share.

 

CAP-XX announces that valid applications were received in respect of, in aggregate, 22,194,995 Offer Shares. Accordingly, the Offer to Qualifying Participants has raised total gross proceeds of approximately £0.67 million.

 

The Offer to Qualifying Participants was in addition to a Placing and a Subscription, also announced on 29 November 2019, which conditionally raised a total of approximately £2.75 million (before expenses).

 

Anthony Kongats, Chief Executive of CAP-XX, commented:

 

"We are delighted with the result of the Offer to Qualifying Participants and wish to thank our shareholders for their support of CAP-XX's strategy."

 

The Offer to Qualifying Participants, together with the Placing and the Subscription, are subject, inter alia, to the approval of Shareholders at a General Meeting to be held at the offices of CAP-XX, Units 9/12 Mars Road, Lane Cove, Australia at 6:00 p.m. AEDT (being 7.00 a.m. GMT) on 30 December 2019.

 

Application has been made to the London Stock Exchange for the New Ordinary Shares to be issued in relation to the Offer to Qualifying Participants, the Placing and the Subscription to be admitted to trading on AIM. It is expected that, subject to passing the Resolution at the General Meeting and the Placing and Offer to Qualifying Participants becoming unconditional in all respects (save for Admission), Admission will become effective, and dealings in the New Ordinary Shares will commence, at 8:00 a.m. GMT on 3 January 2020. Following Admission, the total number of Ordinary Shares and voting rights in the Company will be 438,376,437.

 

 

Capitalised terms used but not defined in this announcement shall have the meanings given to such terms in the announcement issued by the Company on 29 November 2019 unless otherwise defined herein.

 

 

For further information contact:

 

CAP-XX Limited

Anthony Kongats (Chief Executive Officer) +61 (0) 2 9428 0139

 

Allenby Capital (Nominated Adviser and Broker)

David Hart / Alex Brearley +44 (0) 20 3328 5656

 

Kreab (Financial PR)

Robert Speed +44 (0) 20 7074 1800

 

 

More information is available at www.cap-xx.com

 

Notes to Editors:

 

CAP-XX (LSE: CPX) is a world leader in the design and manufacture of thin, prismatic supercapacitors and energy management systems used in portable and small-scale electronic devices, and to an increasing extent, in larger applications such as automotive and renewable energy. The unique feature of CAP-XX supercapacitors is their very high power density and high energy storage capacity in a space-efficient prismatic package. These attributes are essential in power-hungry consumer and industrial electronics, and deliver similar benefits in automotive and other transportation applications. For more information about CAP-XX, visit www.cap-xx.com

 

 

-ENDS-

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ROIGGBDDLGDBGCS
Date   Source Headline
7th May 202410:10 amRNSHolding(s) in Company
7th May 20247:00 amRNSTrading Update
1st May 202411:08 amRNSHolding(s) in Company
30th Apr 20245:00 pmRNSTotal Voting Rights
25th Apr 20249:24 amRNSHolding(s) in Company
24th Apr 20245:04 pmRNSN05/24 - CAP-XX Limited - Restoration of trading
23rd Apr 20248:36 amRNSResult of General Meeting
8th Apr 20249:12 amRNSLitigation with Kyocera AVX settled
28th Mar 20245:00 pmRNSTotal Voting Rights
27th Mar 20248:22 amRNSSuspension of trading
27th Mar 20247:29 amRNSN04/24 - CAP-XX Limited - Suspension of trading
25th Mar 20247:00 amRNSResult of Retail Offer and Total Voting Rights
22nd Mar 20247:00 amRNSResult of Placing and Notice of General Meeting
21st Mar 20244:40 pmRNSREX Retail Offer
21st Mar 20244:35 pmRNSProposed Placing and Subscription to raise £2.0m
21st Mar 20249:00 amRNSLitigation Settlement Agreement with Tesla, Inc
19th Mar 202412:31 pmRNSHolding(s) in Company
18th Mar 20242:56 pmRNSHolding(s) in Company
15th Mar 202412:50 pmRNSHolding(s) in Company
15th Mar 20247:07 amRNSHolding(s) in Company
14th Mar 20247:00 amRNSUpdate on litigation
13th Mar 20247:00 amRNSCorporate Update
12th Mar 20247:00 amRNSRetirement of CFO
28th Feb 20247:00 amRNSUpdate on litigation and trading
19th Feb 20247:00 amRNSCessation of appeals process
1st Feb 20247:00 amRNSInterim Results
29th Jan 20247:00 amRNSUpdate on Patent Infringement
22nd Jan 202412:57 pmRNSChange of Joint Broker
10th Jan 20247:02 amRNSUpdate on IP and appeals process
29th Dec 20231:00 pmRNSTotal Voting Rights
21st Dec 20237:00 amRNSTrading Update
18th Dec 20237:00 amRNSUpdate on Patent Infringement
7th Dec 20237:00 amRNSCAP-XX finalises two new patents
5th Dec 20237:00 amRNSIssue of Shares and Director/PDMR Shareholdings
1st Dec 20237:00 amRNSUpdate re. R&D rebate and other matters
29th Nov 20237:00 amRNSHolding(s) in Company
22nd Nov 202311:29 amRNSHolding(s) in Company
3rd Nov 20239:05 amRNSResult of AGM and Directorate Change
3rd Nov 20237:05 amRNSAGM Trading Update
26th Oct 20232:05 pmRNSHolding(s) in Company
13th Oct 20239:45 amRNSNotice of AGM
4th Oct 20237:00 amRNSExpansion of sales operations
29th Sep 20237:00 amRNSAudited results for the year ended 30 June 2023
14th Sep 202312:29 pmRNSHolding(s) in Company
2nd Aug 20237:00 amRNSPre-close Trading Update and Notice of Results
31st Jul 20239:53 amRNSHolding(s) in Company
18th Jul 202310:27 amRNSUpdate on Patent Infringement
30th Jun 20235:00 pmRNSTotal Voting Rights
13th Jun 20237:00 amRNSHolding(s) in Company
9th Jun 20237:53 amRNSAppointment of Chief Executive Officer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.